BioSpace News Archive

Four in five Canadians (82%) know to look for a MedicAlert medical ID if they come across someone in an emergency situation, according to a new Maru/Matchbook survey conducted on behalf of MedicAlert Foundation Canada.

Ironwood Pharmaceuticals, Inc. provided an update on its first quarter 2018 results and recent business activities.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed? or the “Company”) announced today that it will host a conference call and webcast on Wednesday, May 9, 2018, to provide an update on current developments with respect to its clinical programs for Aramchol™ and to discuss financial results for the three months ended March 31, 2018.

Kush Bottles, Inc. announced it has partnered with MainStem, a technology-based ancillary product distribution company for the regulated cannabis industry, to be the inaugural partner for MainStem’s Vendor Program (MVP).

AgenTus Therapeutics announced that Dr. Andy Hurwitz, Vice President, Head of Preclinical Research, AgenTus Therapeutics will present at the PEGS Summit in Boston on May 2, 2018.

Roche Diabetes Care announced the launch of #BuckOffDiabetes.

Johnson & Johnson Vision today presented new data on the discovery of antioxidant properties of the ultraviolet (UV) blocker in ACUVUE® Brand Contact Lenses at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii.

CRH Medical Corporation announces that it has completed an accretive transaction whereby CRH has acquired a 51% interest in a gastroenterology (“GI”) anesthesia practice in Dayton, Ohio.

Henry Schein, Inc. announced that James P. Breslawski has been named Vice Chairman of the Company, in addition to his role as President of Henry Schein.

Addition of high-throughput technologies and expanded pharmacokinetic services enhances existing support for small molecule drug discovery